Authored By: Sarah
05 Oct 2021

Travel Vaccines Market: Leading Regions and Market Trends

Geographical Analysis and Market Highlights 2021-2025

The travel vaccines market is set to post an incremental growth of $ 2.23 bn, accelerating at a CAGR of almost 9% during the forecast period. Our market investigates the key markets and the factors that are likely to boost growth along with challenges that need to be surpassed to promote success in the market. The report also provides an analysis of key segments and offers competitive benchmarking of the key market players and their product portfolios.


For market insights and a better understanding of the quality of our research: Request for our FREE Sample Report


Travel Vaccines Market: North America to lead market growth during the forecast period

  • 41% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Travel Vaccines Market size.
  • This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. One of the factors that will drive growth is the increase in global travel and migration.  Our analysis will thus enable clients to assess their play in the market and design further growth opportunities.
  • Market is segmented by Type (Influenza, Diphtheria, Hepatitis, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)).

Travel Vaccines Market to Post Incremental Growth of $ 2.23 bn During 2021-2025 | Key Geographies that will Drive Growth

Travel Vaccines Market: Competitive Landscape

Some of the leading vendors in this market are Bharat Biotech Ltd., CSL Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., SK Chemicals Co. Ltd., and Takeda Pharmaceutical Co. Ltd.. The market is fragmented and the growth of the players in this market is dependent on several factors such as prevalent market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.

For more insights on this market: Download a Free Sample Report

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of almost 9%.
     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 2.23 bn through 2021-2025.
     
  3. What is a key factor driving this market?
    Increase in global travel and migration will drive market growth over the forecast period.
     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and Rest of World (ROW) are the key regions featured in this research report.
     
  5. Which is the leading geographic region for this market:
    41% growth will originate from North America
     
  6. Who are the leading market vendors?
    The leading vendors in this market are Bharat Biotech Ltd., CSL Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., SK Chemicals Co. Ltd., and Takeda Pharmaceutical Co. Ltd.
     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Influenza, Diphtheria, Hepatitis, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)).

Market Segmentation by Type

    • Travel Vaccines Market Split by Type
      • Influenza
      • Diphtheria
      • Hepatitis
      • Others
    • Travel Vaccines Market Split by Geography
      • North America
      • Europe
      • Asia
      • Rest of World (ROW)

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2020-2025
  • MEA - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • South America - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Bharat Biotech Ltd.
  • CSL Ltd.
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • SK Chemicals Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.

Travel Vaccines Market: Key Geographies that will Drive Growth

Regional Growth Analysis and Market Trends 2021-2025

The travel vaccines market is set to grow by $ 2.23 billion, accelerating at a CAGR of almost 9% during the forecast period. This research report analyses the growth trajectory of the market with a purview to prevalent market scenario, trends, and drivers. It also provides competitive bench-marking of the key market players and their product portfolios.


For a glimpse into our research analysis and insights: Request for our Free Sample Report


Travel Vaccines Market: North America to lead market growth during the forecast period

  • 41% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Travel Vaccines Market size.
  • Increase in global travel and migration will be a significant factor in driving the growth of the travel vaccines market. This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will thus enable clients to assess their play in the market and plan for growth opportunities.
  • Market is segmented by Type (Influenza, Diphtheria, Hepatitis, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)).

Travel Vaccines Market to Post Incremental Growth of $ 2.23 bn During 2021-2025 | Key Geographies that will Drive Growth

Travel Vaccines Market: Key Competitors

The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Bharat Biotech Ltd., CSL Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., SK Chemicals Co. Ltd., and Takeda Pharmaceutical Co. Ltd. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Explore Technavio’s Research on other Related Markets for more insights:

  1. Human Combination Vaccines Market: Global human combination vaccines market will post an incremental growth of $ 7.16 billion and progressing at a CAGR of 8.80% during the forecast period. Request for Our FREE Sample Report
  2. Human Vaccine Market: Technavio has been monitoring the human vaccine market and it is expected to grow by $ 18.52 billion, decelerating at a CAGR of almost 7% during the forecast period. Request for our FREE Sample Report
  3. Vaccines Market: Technavio has been monitoring the global vaccines market and it is expected to grow by $ 22.29 billion, decelerating at a CAGR of almost 7% during the forecast period.  Request for our FREE Sample Report
  4. Dengue Vaccine Market: Technavio research projects the dengue vaccine market to grow by $ 132.90 million, accelerating at a CAGR of over 18% till 2025.  Request for our FREE Sample Report

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of almost 9%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 2.23 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    Increase in global travel and migration will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and Rest of World (ROW) are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    41% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are Bharat Biotech Ltd., CSL Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., SK Chemicals Co. Ltd., and Takeda Pharmaceutical Co. Ltd.

     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Influenza, Diphtheria, Hepatitis, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)).

For more insights on this market: Download a Free Sample Report

Travel Vaccines Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

Technavio has been monitoring the travel vaccines market and it is expected to grow by $ 2.23 bn, accelerating at a CAGR of almost 9% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking


Travel Vaccines Market: Receive Free Sample Report


Travel Vaccines Market: Key Trends to impact market growth

Changes in the demographic profile of travelers globally is one of the key travel vaccines market trends. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.

Travel Vaccines Market: Top Drivers to Boost Demand

Increase in global travel and migration is one of the primary factors driving the growth of the travel vaccines market. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business

Travel Vaccines Market to Post Incremental Growth of $ 2.23 bn During 2021-2025 | Key Geographies that will Drive Growth

For more insights on this market: Download a Free Sample Report

Travel Vaccines Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive travel vaccines market growth during the next five years
  • Precise estimation of the travel vaccines market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the travel vaccines market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of travel vaccines market vendors
Read News Read Less
Interested in this report?
Get your sample now!
Technavio